Literature DB >> 233901

Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

R B Effros1, P C Doherty, W Gerhard, J Bennink.   

Abstract

Specificity of cytotoxic T-cell function was investigated for a range of different influenza viruses. T cells from mice immunized with A or B strain influenza viruses, or with vaccinia virus, showed reciprocal exclusion of cytotoxicity. Extensive cross-reactivity was, however, found for lymphocyte populations from mice infected with a variety of serologically distinct influenza A viruses, though serum antibodies did not cross-react when tested in a radioimmunoassay using comparable target cells as immunoadsorbents. This apparent lack of T-cell specificity was recognized for immune spleen cells generated after intraperitoneal inoculation of high titers of virus, and for mediastinal lymph node populations from mice with pneumonia due to infection with much less virus. The phenomenon could not be explained on the basis of exposure to the chicken host component, which is common to A and B strain viruses. However, not all of the virus-immune T-cell clones are cross-reactive. Competitive-inhibition experiments indicate that a considerable proportion of the lymphocyte response is restricted to the immunizing virus. Even so, the less specific component is significant. Also, exposure to one type A virus was found to prime for an enhanced cell-mediated immunity response after challenge with a second, serologically different A strain virus.

Entities:  

Mesh:

Year:  1977        PMID: 233901      PMCID: PMC2180700          DOI: 10.1084/jem.145.3.557

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Virus-specific T-cell-mediated cytotoxicity across the H-2 barrier to virus-altered alloantigen.

Authors:  R M Zinkernagel
Journal:  Nature       Date:  1976-05-13       Impact factor: 49.962

2.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

3.  Defining the heterogeneity of anti-tumor antibody responses.

Authors:  G P Segal; N R Klinman
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

4.  Mode of action of Ir genes and the nature of T cell receptors for antigen.

Authors:  R V Blanden; A J Hapel; D C Jackson
Journal:  Immunochemistry       Date:  1976-02

5.  Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity.

Authors:  P C Doherty; R V Blanden; R M Zinkernagel
Journal:  Transplant Rev       Date:  1976

6.  Cell-mediated immune response to influenza virus infections in mice.

Authors:  G Cambridge; J S Mackenzie; D Keast
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

7.  Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. II. Determination of frequency and characteristics of idiotypic T and B lymphocytes in normal rats using direct visualization.

Authors:  H Binz; H Wigzell
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

8.  H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras.

Authors:  R M Zinkernagel
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

9.  A single genetic element in H-2K affects mouse T-cell antiviral function in poxvirus infection.

Authors:  U Kees; R V Blanden
Journal:  J Exp Med       Date:  1976-02-01       Impact factor: 14.307

10.  Idiotypic analysis of lymphocytes in vitro. I. Specificity and heterogeneity of B and T lymphocytes reactive with anti-idiotypic antibody.

Authors:  S J Black; G J Hämmerling; C Berek; K Rajewsky; K Eichmann
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  108 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

Authors:  Susan L Swain; Javed N Agrewala; Deborah M Brown; Dawn M Jelley-Gibbs; Susanne Golech; Gail Huston; Stephen C Jones; Cris Kamperschroer; Won-Ha Lee; K Kai McKinstry; Eulogia Román; Tara Strutt; Nan-ping Weng
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

3.  Toward a broadly protective influenza vaccine.

Authors:  Peter C Doherty; Anne Kelso
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 4.  Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly.

Authors:  R B Effros
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

Review 5.  Virus-immune T cells and the major histocompatibility complex: evolution of some basic concepts over the past two years.

Authors:  P C Doherty
Journal:  Experientia       Date:  1986-09-15

6.  Interaction of influenza A virus with human peripheral blood lymphocytes.

Authors:  J M Brownson; B W Mahy; B L Hazleman
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

7.  Cellular changes in lungs of mice infected with influenza virus: characterization of the cytotoxic responses.

Authors:  P R Wyde; T R Cate
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

8.  Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride.

Authors:  W C Koff; D L Peavy; V Knight
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines.

Authors:  Janet E McElhaney
Journal:  Aging health       Date:  2008-12-01

Review 10.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.